Search Results 1011-1020 of 17782 for monoclonal antibody
Cohort A will enroll participants who have progressed on prior standard of care treatment with an anti-PD-1/PD-L1 antibody and a platinum-based chemotherapy ...
... monoclonal gammopathy of thrombotic significance (MGTS). ... antibody detection. Researchers are beginning to ... Monoclonal gammopathy of thrombotic ...
Heavy Chain/Light Chain Antibody Immunofluorescence to Identify Monoclonal Plasma Cells in a Case of Plasma Cell-Rich Acute Interstitial Nephritis. Kidney ...
The goal of this study is to validate testing to be performed in the clinical immunology lab and have a source of positive patient sera. These tests include:.
Outcomes of triple class (proteasome inhibitor, IMiDs and monoclonal antibody) refractory patients with multiple myeloma. Leukemia 2022 Mar; 36 (3):873-876 ...
an anti-CD38 monoclonal antibody. - Permitted to be venetoclax or BCL-2 inhibitor exposed in previous lines of therapy. - Life expectancy ≥ 12 weeks ...
... monoclonal antibody; Relapsed or refractory disease defined as 1 or more of the following: Stable disease or Progressive disease (PD) as best response to ...
Significant allergy to humanized monoclonal antibodies. Clinically significant multiple or severe drug allergies, or severe post-treatment hypersensitivity ...
“BEXXAR is an intravenous monoclonal antibody that's directed against the proteins located ... Monoclonal antibodies identify the bad cancer cells and ...
those antibodies. There are antiviral drugs like remdesivir, there are monoclonal antibody drugs that are being developed. Right now, the ones that are ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!